PHGE
AMEXBiomX Inc.
Price$0.67-5.66 (-89.47%)
2026-03-052026-06-08
News · 26 weeks57+100%
2025-12-142026-06-07
Mix3390d
- SEC Filings16(48%)
- Other11(33%)
- Leadership3(9%)
- Insider2(6%)
- M&A1(3%)
Latest news
25 items- SECSEC Form DEF 14A filed by BiomX Inc.DEF 14A - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRAnother Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at ElbitNETANYA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), today announced the appointment of Prof. Gabby Sarusi as Strategic Advisor to the Company. Prof. Sarusi will advise BiomX as the Company as the company expands its presence in the defense, security, critical infrastructure, and first-response sectors, and drawing on his experience spanning technology development, operational leadership, and long-term strategic planning. His advisory role is expected to support management in evaluating new opportunities and advancing the Company's long-term growth strategy. Prof. Sarusi brings a combination of scientific, defense-industry, commercial, and
- PRZorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud DependenceNETANYA, Israel, June 01, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), today announced the expansion of its Zorronet subsidiary's autonomous C5ISR suite to support fully secure on-premise, hybrid, and closed-loop deployments for defense, security, and critical infrastructure. The expanded offering enables organizations to run the full Zorronet C5ISR suite inside hardened sites, secured intranets, and restricted infrastructure without relying on the public cloud. The expansion reflects growing demand for autonomous command-and-control systems that can function locally inside secured infrastructure, a priority highlighted by US President Donald Trump's push to
- SECAmendment: SEC Form SCHEDULE 13D/A filed by BiomX Inc.SCHEDULE 13D/A - BiomX Inc. (0001739174) (Subject)
- SECBiomX Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX Appoints IDF Colonel (res.) Roy Timor-Rousso as Chief Business Officer to Strengthen Defense & Security OperationsNETANYA, Israel, May 27, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), today announced the appointment of Roy Timor-Rousso as Chief Business Officer (CBO), adding senior business & operational leadership as the Company continues building around defense, security, and first response technologies. As a Colonel (res.) in the Israel Defense Forces, Mr. Timor-Rousso's military leadership experience gives him direct understanding of operational command, field coordination, and how technology must serve soldiers and operators on the ground. Bringing on Mr. Timor-Rousso further strengthens BiomX's operating structure with leadership experience in coordinating subsid
- SECSEC Form 10-Q filed by BiomX Inc.10-Q - BiomX Inc. (0001739174) (Filer)
- SECSEC Form NT 10-Q filed by BiomX Inc.NT 10-Q - BiomX Inc. (0001739174) (Filer)
- PRBiomX's Zorronet Puts Full AI Command-and-Control in the Palm of Your HandNETANYA, Israel, May 06, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company") today announced that its Zorronet subsidiary has launched a secure mobile application that brings its system directly to operators in the field, available now on Google Play and the Apple App Store, and is available for all customers. Zorronet develops AI-powered software that connects cameras, sensors, drones, and IoT devices into a single system. Its technology is already in use in cities and regional councils and across Israel, as well as with Israel Railways, among other organizations. Today, control room operators deal with more data than they can realistically process. Alerts come fr
- SECBiomX Inc. filed SEC Form 8-K: Other Events8-K - BiomX Inc. (0001739174) (Filer)
- SECAmendment: SEC Form 10-K/A filed by BiomX Inc.10-K/A - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Other Events, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRZorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection SystemsNETANYA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company") today highlighted the successful deployment of its Zorronet subsidiary in collaboration with Israel Railways, focused on protecting wildlife and safeguarding national infrastructure. Over the past year, a large-scale pilot project, with an investment by Israel Railways of approximately NIS 800,000, was completed and declared a success. The project achieved a success rate of 98% at keeping large animals - including wild boar, foxes, and gazelles - off of railway tracks in the sections it was deployed in. These animals would otherwise have wandered onto the tracks, thereby preserving ecolog
- SECAmendment: SEC Form SCHEDULE 13D/A filed by BiomX Inc.SCHEDULE 13D/A - BiomX Inc. (0001739174) (Subject)
- SECBiomX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX Accelerates Defense Technology Buildout with DFSL AcquisitionNETANYA, Israel, April 13, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company") today announced that it has accelerated the exercise of its previously disclosed exclusive option and entered into a definitive agreement to acquire a controlling interest in DFSL, an Israeli defense engineering company that develops a proprietary LADAR (Laser Radar)–based detection systems in the perimeter security, critical infrastructure and counter-UAS markets. This transaction marks the next step in BiomX's expansion into the defense sector, adding a second, complementary capability to its portfolio. With DFSL's deployed, high-precision LADAR technology, the company introduces real-t
- SECSEC Form S-8 filed by BiomX Inc.S-8 - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security ApplicationsNETANYA, Israel and REHOVOT, Israel, April 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) (the "Company") today announced that it has completed the acquisition of 100% of Zorronet from Water.io (TASE: WATR). This acquisition marks BiomX's entry into the defense, security and rescue sector and establishes a foundation for building a diversified portfolio of defense, rescue, and security capabilities aligned with growing global demand. The acquisition was completed pursuant to a definitive agreement with Water.io. Zorronet is a developer of AI-powered command-and-control software that uses artificial intelligence and machine learning to integrate video analytics, drones, sensors, and I
- SECBiomX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone SystemNETANYA, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) today announced that it has entered into an option agreement to acquire control of DFSL, a developer of proprietary LADAR (Laser Radar)–based detection systems for security, defense, and critical infrastructure applications. DFSL's LADAR technology combines laser-based sensing with proprietary AI algorithms to detect and respond to both UAV and ground-based intruders. BiomX intends to exercise the option subject to the closing of the underlying agreement and obtaining shareholder approval as necessary or consideration consisting of a combination of cash, promissory note, shares of common stock and warrants. Separat
- PRBiomX Adds Former Mossad Deputy to Advisory BoardNETANYA, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE), today announced the appointment of Dr. Ehud (Udi) Levi to its newly formed Advisory Board. Dr. Levi will support the Company in evaluating and pursuing strategic alternatives and business opportunities, with an emphasis on security and defense, aerial response systems, and counter-UAS (C-UAS) technologies. This will include identifying and assessing potential partnerships, transactions, and new business directions aligned with the Company's expansion into security and defense applications. Dr. Levi brings more than three decades of experience in Israeli intelligence and national security. He served in Unit 8200
- SECBiomX Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
PHGE FAQ
7 questionsWhat does BiomX Inc. do?
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). The company's lead product candidate BX001, which is in Phase II that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type. Its products under...Where does PHGE stock trade?
BiomX Inc. (PHGE) is listed on AMEX.What sector and industry is PHGE in?
BiomX Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did BiomX Inc. go public?
BiomX Inc. (PHGE) completed its IPO in 2019.What are analysts saying about PHGE?
BiomX Inc. has had 3 recent analyst actions on file. The most recent action was from Chardan Capital: Buy with a $1300.00 price target on 2021-11-16. Recent price targets range from $1000.00 to $1600.00.What companies are similar to PHGE?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare PHGE side-by-side with any of them on Quantisnow.How can I track PHGE on Quantisnow?
Quantisnow aggregates BiomX Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PHGE to receive live email and push alerts on every new disclosure.